| 3/9/2021 | BKCVDDEMIGPV | Market Commentary: Primary reasonably busy; secondary firms; Charles River gains; Alcoa in focus
|
| 3/8/2021 | BKCVDDEMIGPV | Market Commentary: Charles River, Alcoa price; forward calendar grows; Playtika holds; Twilio active
|
| 5/1/2019 | BKCVHYIG | S&P lowers Charles River to junk
|
| 2/14/2019 | BKCVHYIG | S&P puts Charles River on watch
|
| 4/10/2018 | BKCVDDEMIGPV | Market Commentary: Hilton, Silversea upsize; junk market strong; Sprint up on merger news; Tenneco down
|
| 3/29/2018 | BKCVDDEMIGPV | Market Commentary: Ply Gem, Wyndham, W/S price; McDermott delayed; recent deals mixed; funds off $0.62 billion
|
| 3/28/2018 | BKCVDDEMIGPV | Market Commentary: Coty, Charles River price; McDermott widens talk; Tronox trades down; Tesla dominates
|
| 4/28/2015 | BKCV | Moody’s rates Charles River revolver, loan Ba2
|
| 6/19/2013 | BKCV | Charles River: Q1 sales rise; refinanced credit agreement won't affect capital deployment, says CFO
|
| 6/11/2013 | BKCV | Moody's rates Charles River Laboratories amended loans Ba2
|
| 3/14/2013 | CV | Market Commentary: Suntech Power active at 30 as potential default looms; Charles River pops; Salesforce quiet around par
|
| 7/31/2012 | CVIGPF | Charles River Labs files automatic shelf for stock, preferreds, debt
|
| 2/21/2012 | BKCV | Moody's: Charles River to SGL-3
|
| 2/14/2012 | CV | Market Commentary: Convertibles weaken some; Gilead mixed; Charles River flat on earnings; DryShips jumps
|
| 12/14/2011 | BKCV | Charles River Labs cuts debt in 2011, targets up to $175 million of free cash flow for 2012
|
| 9/28/2011 | CV | S&P: Charles River unaffected
|
| 9/26/2011 | BKCV | Moody's rates Charles River loan Ba1
|
| 9/23/2011 | CV | Market Commentary: NuVasive seen as interesting story despite Medtronic issues; aircraft, airline space busy
|
| 4/6/2011 | CV | Market Commentary: Fifth Street intends to price $150 million notes; Amerigroup, SM Energy paper cheapening
|
| 2/24/2011 | BKCV | S&P: Charles River loan BBB-
|
| 2/24/2011 | BKCV | Moody's affirms Charles River
|
| 2/10/2011 | CV | Market Commentary: Charles River adds slightly on hedge; Energy Conversion higher; Molycorp upsizes, prices
|
| 8/27/2010 | BKCV | Moody's rates Charles River loans Ba1
|
| 8/3/2010 | BKCV | Moody's drops Charles River Labs loan
|
| 7/30/2010 | BKCV | Moody's: Charles River unaffected
|
| 6/14/2010 | CV | Market Commentary: Transocean fluctuates; Microsoft flat on hedged basis; Chesapeake Energy a little weaker
|
| 6/4/2010 | BKCV | Moody's cuts Charles River, rates loans Ba1
|
| 6/4/2010 | BKCV | S&P affirms Charles River, rates loans BBB-
|
| 5/14/2010 | CV | Market Commentary: Remarketed Stanley in trade at 109; Charles River weaker in active trade; AMD, Intel quiet
|
| 4/27/2010 | BKCV | Moody's may cut Charles River Labs
|
| 4/26/2010 | BKCV | S&P may cut Charles River
|
| 4/26/2010 | BKCV | S&P may cut Charles River
|
| 4/26/2010 | CV | Market Commentary: PMI bid up in gray market; Lennar gray bid tepid; M&A drives trade in Charles River, Hertz
|
| 12/21/2009 | BKCV | Moody's ups Charles River Labs loan
|
| 8/4/2009 | CVIG | Charles River files automatic shelf covering debt, preferreds, stock
|
| 4/23/2009 | BKCV | S&P: Charles River Labs view stable
|
| 3/12/2009 | BKCV | Moody's: Charles River view negative
|
| 8/11/2008 | BKCV | Moody's cuts Charles River to SGL-2
|
| 3/10/2008 | BKCV | Moody's ups Charles River outlook to stable
|
| 2/22/2008 | CVIG | S&P ups Charles River Labs from junk
|
| 9/25/2006 | CV | Market Commentary: Sandisk slips on downgrade; Equity Residential, National Retail gain on rate play; Charles River up on vol
|
| 8/9/2006 | CV | Market Commentary: BRE, Digital Realty bright in the gray; Amkor mixed on delayed filing; Tanger, Retail Ventures plan deals
|
| 8/9/2006 | BTCVHY | Charles River Labs files automatic shelf registration
|
| 7/27/2006 | CV | Market Commentary: Omnicare withstands profit cut; Symantec rises with results; XM unmoved by loss; Weingarten plans deal
|
| 6/19/2006 | BKBTCV | S&P assigns Charles River Laboratories convertibles BB-
|
| 6/13/2006 | CV | Market Commentary: Advanced Medical, Charles River, Nabors gain on volatility; Symantec flat on debut; Nektar drops outright
|
| 6/7/2006 | CV | Market Commentary: Interpublic, Spansion, Charles River climb, Millipore struggles on debuts; Level 3 up in gray; L-3 gains
|
| 6/7/2006 | BTCV | New Issue: Charles River $300 million seven-year convertibles price within talk, at 2.25%, up 22.5%
|
| 6/6/2006 | BTCV | Charles River prices $300 million seven-year convertibles to yield 2.25%, up 22.5%
|
| 6/6/2006 | CV | Market Commentary: New deals seen as unexciting; Spansion structure seen as too long; Charles River, Millipore views mixed
|
| 6/5/2006 | CV | Market Commentary: SanDisk gains outright on stock upgrade; Sepracor falls on probe; Interpublic plans unique deal
|
| 6/5/2006 | BTCV | Charles River Laboratories' $300 million of seven-year convertibles talked at 2%-2.5%, up 22.5%-27.5%
|
| 8/11/2005 | BKBTCV | S&P ups Charles River view to positive
|
| 3/28/2005 | CV | Charles River Labs calls $185 million 3.5% convertibles
|
| 9/14/2004 | BKCV | Moody's rates Charles River loans Ba1
|
| 7/1/2004 | CV | S&P: Charles River Labs unaffected
|
| 2/26/2003 | CV | Moody's ups Alpharma outlook
|
| 1/18/2002 | CV | Market Commentary: Convertibles retreat, healthcare issues hit hard, Tyco takes wild ride
|
| 1/17/2002 | CV | New Issue: Charles River Labs upsized $175 million convertibles at 3.5%, up 30%
|
| 1/17/2002 | CV | Market Commentary: Convertibles rebound in frantic session of earnings news, Ford deal getting launched
|
| 1/16/2002 | CV | Moody's downgrades Kmart two notches, still on review
|
| 1/16/2002 | CV | Market Commentary: Convertibles plunge with stock in hectic session, but new deals keep coming
|
| 1/15/2002 | CV | Charles River Labs $150 million convertibles talked 3.5-4.0% yield, up 24-28%
|
| 1/15/2002 | CV | Market Commentary: Convertibles flat, dull outside of new deal activity
|
